[1] Jain S,Williams DJ,Arnold SR,et al.Community-acquired pneumonia requiring hospitalization among U.S.children[J].NEngl J Med,2015,372(9):835-845. [2] Nisar N,Guleria R,Kumar S,et al .Mycoplasma pneumoniae and its role in asthma [J] .Postgrad Med J,2007,83 (976) :100-104. [3] 中华医学会儿科学分会呼吸组.《儿童支气管哮喘诊断与防治指南(2016修订)》[J].中华儿科杂志,2016,54(3):167-181. [4] 丁林,季伟,孙慧明,等.T淋巴细胞亚群及过敏原与婴幼儿肺炎支原体感染伴喘息的关系[J].中国当代儿科杂志,2016,18(12):1254-1258. [5] 胡亚美,江载芳,申昆玲,等.褚福棠实用儿科学[M].8版.北京:人民卫生出版社,2015:1281-1282. [6] Choi IS,Byeon JH,Yoo Y,et al.Increased serum interleukin-5 and vascular endothelial growth factor in children with acute mycoplasma pneumonia and wheeze[J].Pediatr Pulmonol,2009,44(5):423-428. [7] Esposito S,Blasi F,Arosio C,et al .Importance of acute mycoplasma pneumoniae and chlamydia pneumoniae infections in children with wheezing[J].Eur Respir J,2000,16:1142-1146. [8] 陈广道,陈爱欢.儿童肺炎支原体感染相关喘息的研究进展 [J] 中华儿科杂志,2012,50(10):756-759. [9] 孙红,孙红妹.肺炎支原体直接损伤及其免疫学致病机制研究进展[J].中华微生物学和免疫学杂志,2015,35(1):65-68. [10] 于春琳,赵德育.肺炎支原体肺炎免疫功能与其病情的相关性[J] .江苏医药,2017,43(19):1388-1390. [11] Esposito S,Droghetti R,Bosis S,et al .Cytokine secretion in children with acute mycoplasma pneumoniae infection and wheeze [J] .Pediatr Pulmonol,2002,34(2):122. [12] 陈琳.肺炎支原体肺炎发病机制研究进展[J] .中国城乡企业卫生,2016,10(1):16-19. [13] 周兰芝,牟丹丹,李婷婷,等.儿童难治性支原体肺炎的发病机制及治疗[J].中国妇幼保健,2016,31(8):1786-1788. [14] Bamtt NA,Austen KF.Innate cells and T helper 2 cells immunity in airway inflamation [J] .Immunity,2009,31(3):425-437. [15] 李菁,包军,鲍一笑,等.肺炎支原体肺炎患儿肺泡灌洗液病菌量及其与Th1/Th2细胞免疫应答的关系[J] .临床儿科杂志,2015,33(8):681-685. [16] 罗星星,陈展泽,许扬扬,等.血清IgG4和IgE在儿童过敏性哮喘和过敏性鼻炎中的应用[J].国际检验医学杂志,2017,38(4):442-445. [17] 李政锦,周文,彭昌,等.小儿肺炎支原体感染后免疫功能变化的研究[J].中华医院感染学杂志,2012,22(15):3221-3223. |